CITIUS ONCOLOGY, INC. (CTOR) Operating income 2022–2025
CITIUS ONCOLOGY, INC. (CTOR) annual operating income history from SEC filings — each fiscal year as reported.
-$23.5MFY2025 · since FY2022: -$138,115 → -$23.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.5M | -14.3% |
| FY2024 | -$20.6M | -1930.7% |
| FY2023 | -$1.0M | -633.5% |
| FY2022 | -$138,115 | — |
Source: SEC XBRL filings · For reference only · Not investment advice